Pharmacologic Therapy for COVID-19 Infection

The COVID-19 pandemic has focused attention on issues of epidemiology, public health, and vaccine design. I submit that attention to COVID-19 pharmacologic therapy needs similar emphasis, including identifying any existing medications that can be repurposed to treat COVID-19 patients.

Detalles Bibliográficos
Autor principal: Nusbaum, Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169637/
https://www.ncbi.nlm.nih.gov/pubmed/32314081
http://dx.doi.org/10.1007/s10900-020-00821-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169637/
https://www.ncbi.nlm.nih.gov/pubmed/32314081
http://dx.doi.org/10.1007/s10900-020-00821-z

Ejemplares similares